
Global markets are evolving day by day. Let competitors swoop in first, and your growth opportunities get harder to find. Businesses need to know where to play and how to win. They need comprehensive and predictive global market opportunity assessments for successful new market entry. Be ready for your next window of opportunity.

New market entry is a game of high risk, high reward. A brand’s formula for success in one geography or category can backfire in another. A host of factors are at play with any new market entry. Market-specific economic drivers can impact buying power and price sensitivity. Complex social and cultural forces shape perception and behavior. Not to mention government and regulatory hurdles, intricate distribution ecosystems, and well-established competitors in your way.
Escalent helps expansion-focused brands reformulate for success. We closely assess opportunity and hedge risk with an all-encompassing, geographically nuanced market assessment to inform your next strategic market entry.
Using multiple methodologies and data sources, Escalent gives you a comprehensive view of risk and reward. We’ll often start with a customized assessment of market potential. The assessment looks at many market factors in conjunction with your core brand proposition, product benefits, and your ability to deliver in the market. We consider a mix of market externalities and your business strengths to recommend priority target markets. So, you’ll know where to play and how to win.
And it’s not all about new market entry. Escalent’s framework is designed to help you defend your existing markets from challengers looking to steal share.
Ask about our strategic market assessment and new market entry support.
Discover some of the most telling findings from our 2025 research among the top three stakeholders in the DC plan market: plan advisors, plan sponsors and plan participants.
New data from Cogent Syndicates reveal that advisor adoption and allocation patterns to alternative investments are shifting faster than expected, signaling a fundamental change in how wealth managers approach portfolio construction.
AI is no longer an emerging concept for US healthcare. It is already deeply embedded and transforming how care is delivered, how clinicians work and how patients experience the system. As market researchers, this shift is not just interesting background context. It fundamentally changes how healthcare insights are generated, what questions matter, which stakeholders influence decisions and where new opportunities emerge.
New findings from Cogent Syndicated reveal inheritors' growing preference for integrated advice as average anticipated inheritances double to $1 million
New Escalent data reveals the number of "technical" advisors has dropped to 36% as professionals focus on client acquisition
New research from Escalent shows one quarter of DC advisors likely to recommend alternatives, with National, large-scale producers driving the trend